Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Return on Capital Employed (2016 - 2020)

Historic Return on Capital Employed for Larimar Therapeutics (LRMR) over the last 7 years, with Q1 2020 value amounting to 1.21%.

  • Larimar Therapeutics' Return on Capital Employed fell 6400.0% to 1.21% in Q1 2020 from the same period last year, while for Mar 2020 it was 1.21%, marking a year-over-year decrease of 6400.0%. This contributed to the annual value of 0.79% for FY2019, which is 1800.0% down from last year.
  • Per Larimar Therapeutics' latest filing, its Return on Capital Employed stood at 1.21% for Q1 2020, which was down 6400.0% from 1.06% recorded in Q4 2019.
  • In the past 5 years, Larimar Therapeutics' Return on Capital Employed registered a high of 0.46% during Q4 2016, and its lowest value of 1.21% during Q1 2020.
  • For the 5-year period, Larimar Therapeutics' Return on Capital Employed averaged around 0.62%, with its median value being 0.57% (2017).
  • Its Return on Capital Employed has fluctuated over the past 5 years, first skyrocketed by 1600bps in 2019, then tumbled by -6400bps in 2020.
  • Over the past 5 years, Larimar Therapeutics' Return on Capital Employed (Quarter) stood at 0.46% in 2016, then fell by -24bps to 0.57% in 2017, then grew by 5bps to 0.54% in 2018, then tumbled by -97bps to 1.06% in 2019, then decreased by -15bps to 1.21% in 2020.
  • Its Return on Capital Employed was 1.21% in Q1 2020, compared to 1.06% in Q4 2019 and 0.65% in Q3 2019.